1. Risk and Predictors of Mortality Associated With Chronic Hepatitis B Infection 
Uchenna H. Iloeje, Hwai–I. Yang, Chin–Lan Jen, Jun Su, Li–Yu Wang, San–Lin You, Chien–Jen Chen 
Clinical Gastroenterology and Hepatology 
Volume 5, Issue 8, Pages (August 2007)
DOI: /j.cgh
Copyright © 2007 AGA Institute Terms and Conditions

2. Figure 1 Study design and flow chart.
Clinical Gastroenterology and Hepatology 2007 5, DOI: ( /j.cgh )
Copyright © 2007 AGA Institute Terms and Conditions

3. Figure 2 Total mortality according to HBsAg serostatus (n = 22,472).
Clinical Gastroenterology and Hepatology 2007 5, DOI: ( /j.cgh )
Copyright © 2007 AGA Institute Terms and Conditions

4. Figure 3
(A) Total mortality according to baseline HBV DNA level in HBsAg-positive subjects without evidence of HCV infection (n = 3653). (B) Liver-related mortality according to baseline HBV DNA level in HBsAg-positive subjects without evidence of HCV infection (n = 3653). (C) Non–liver-related mortality according to baseline HBV DNA level in HBsAg-positive subjects without evidence of HCV infection (n = 3653).
Clinical Gastroenterology and Hepatology 2007 5, DOI: ( /j.cgh )
Copyright © 2007 AGA Institute Terms and Conditions

5. Figure 3
(A) Total mortality according to baseline HBV DNA level in HBsAg-positive subjects without evidence of HCV infection (n = 3653). (B) Liver-related mortality according to baseline HBV DNA level in HBsAg-positive subjects without evidence of HCV infection (n = 3653). (C) Non–liver-related mortality according to baseline HBV DNA level in HBsAg-positive subjects without evidence of HCV infection (n = 3653).
Clinical Gastroenterology and Hepatology 2007 5, DOI: ( /j.cgh )
Copyright © 2007 AGA Institute Terms and Conditions